Arcellx (ACLX) Receivables - Other (2023)
Arcellx's quarterly Receivables - Other came in at $31.5 million in Q3 2023, up 6.96% quarter-over-quarter from $29.4 million in Q2 2023.
Arcellx has reported Receivables - Other for 1 years, with the latest figure at $31.5 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 31.48 Mn |
| Sep 30, 2023 | 31.48 Mn |
| Jun 30, 2023 | 29.43 Mn |
| Jun 30, 2023 | 29.43 Mn |
| Mar 31, 2023 | 21.23 Mn |
| Mar 31, 2023 | 21.23 Mn |